ProfileGDS5822 / ILMN_2705176
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 69% 75% 72% 73% 72% 71% 56% 68% 67% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 147.569
GSM1276600PDAC Late Ablation Control 289.475
GSM1276601PDAC Late Ablation Control 389.972
GSM1276602PDAC Late Ablation 163.473
GSM1276603PDAC Late Ablation 270.272
GSM1276604PDAC Late Ablation 363.471
GSM1303940PDAC Late Ablation_anti-CTLA4 125.756
GSM1303941PDAC Late Ablation_anti-CTLA4 259.168
GSM1303942PDAC Late Ablation_anti-CTLA4 357.367